🇺🇸 Glulisine in United States

842 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Blood Glucose Increased — 110 reports (13.06%)
  2. Dyspnoea — 102 reports (12.11%)
  3. Hypoglycaemia — 98 reports (11.64%)
  4. Hyperglycaemia — 97 reports (11.52%)
  5. Fatigue — 76 reports (9.03%)
  6. Vomiting — 76 reports (9.03%)
  7. Glycosylated Haemoglobin Increased — 75 reports (8.91%)
  8. General Physical Health Deterioration — 71 reports (8.43%)
  9. Dizziness — 70 reports (8.31%)
  10. Diarrhoea — 67 reports (7.96%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Glulisine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Glulisine in United States?

Emory University is the originator. The local marketing authorisation holder may differ — check the official source linked above.